PFE - 2 Top Cancer Treatment Stocks to Buy in June
June holds plenty of catalysts for biotechnology stocks -- especially those specializing in cancer treatments. Investors with extra cash on the sidelines may be able to capture some exciting cancer stocks at attractive prices. These small-cap biotechnology stocks when held in the long term can be lucrative and see plenty of upside from the successes in the drug development process. Here is a look at two promising small-cap biotechnology names that may take the oncology market by storm.
Both companies have first-in-class therapies at the cutting edge of science. One company received approval from the Food and Drug Administration (FDA) for its cancer drug and is expanding to other indications. Another offers a promising pipeline with a strong patent portfolio that is in the process of regulatory submission. Let's take a closer look.
Image source: Getty Images.